ITA3199
ITA3199
- Catalog: ITA3199
- Gene/Protein: PPP1R10
- Product Description: Immunotag™ PPP1R10 Antibody
385.0000
Price in reward points: 385
Your shopping cart is empty!
Antibody Specification | |
Datasheet | |
Target Protein | PPP1R10 |
Clonality | Polyclonal |
Storage/Stability | -20°C/1 year |
Application | WB,ELISA |
Recommended Dilution | WB 1:500-1:2000 |
Concentration | 1 mg/ml |
Reactive Species | Human,Mouse,Rat |
Host Species | Rabbit |
Immunogen | A synthesized peptide |
Specificity | PPP1R10 antibody detects endogenous levels of total PPP1R10 |
Purification | The antiserum was purified by peptide affinity chromatography. |
Form | Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Gene Name | PPP1R10 |
Accession No. | Q96QC0 |
Alternate Names | CAT 53; CAT53; FB 19; FB19; FB19 protein; HLA-C associated transcript 53; MHC class I region proline rich protein CAT53; p99; Phosphatase 1 nuclear targeting subunit; Phosphatase nuclear targeting subunit; PNUTS; PP1 binding protein of 114 kDa; PP1 nuclear targeting subunit; PP1R10; protein FB19; Protein phosphatase 1 nuclear targeting subunit; Protein phosphatase 1 regulatory (inhibitor) subunit 10; Protein phosphatase 1 regulatory subunit 10; R111; Serine/threonine protein phosphatase 1 regulatory subunit 10; |
Description | Scaffold protein which mediates the formation of the PTW/PP1 phosphatase complex by providing a binding platform to each component of the complex. The PTW/PP1 phosphatase complex plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. Mediates interaction of WDR82 and PPP1CA. Inhibitor of PPP1CA and PPP1CC phosphatase activities. Has inhibitory activity on PPP1CA only when phosphorylated. Binds to mRNA, single-stranded DNA (ssDNA), poly(A) and poly(G) homopolymers (By similarity). |
Cell Pathway/ Category | Primary Polyclonal Antibody |
Protein MW | 99 kDa |
Usage | For Research Use Only! Not for diagnostic or therapeutic procedures. |